Regeneron(REGN) - 2024 Q3 - Quarterly Results

Exhibit 99.1 REGENERON Press Release Regeneron Reports Third Quarter 2024 Financial and Operating Results • Third quarter 2024 revenues increased 11% to $3.72 billion versus third quarter 2023 • Third quarter 2024 Dupixent global net sales (recorded by Sanofi) increased 23% to $3.82 billion versus third quarter 2023 • Third quarter 2024 U.S. net sales for EYLEA HD and EYLEA increased 3% versus third quarter 2023 to $1.54 billion, including $392 million from EYLEA HD • Third quarter 2024 Libtayo global net s ...